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Abstract: 
 
Bioassay guided fractionation of an antimycobacterial extract of Arracacia tolucensis var. 
multifida (Umbelliferae) led to the isolation of isoimperatorin (1), osthol (2), suberosin (3), 8-
methoxypsoralen (8-MOP) (4), herniarin (5), scoparone (6), umbelliferone (7), 
dihydroxypeucedanin (8), 5-methoxypsoralen (5-MOP) (9), isoscopoletin (10) and scopoletin 
(11). The isolates were tested against Mycobacterium tuberculosis and only 1–4 showed 
significant activity with MIC values of 64, 32, 16 and 128 μg/mL, respectively. The essential oil 
showed moderate in vitro antibacterial activity against representative Gram-positive and Gram-
negative bacteria. The volatile oil of Arracacia tolucensis var. multifida was analyzed by GC–
MS and found to be composed mainly by 2 and 3. The essential oil (IC50 = 116.4 ± 23.2 μg/mL) 
and the extract (IC50 = 1153.1 ± 53.2 μg/mL) of the plant provoked concentration dependent 
inhibition of the tone and amplitude of the guinea-pig ileum spontaneous contractions; the latter 
activity was related with the high coumarin content of this species. A suitable (novel and rapid) 
HPLC method to quantify the major active coumarins of the plant was developed. The method 
provides also a reproducible fingerprint useful for identity tests of this plant. 
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Article: 
 
1. Introduction 
 
Arracacia tolucensis var. multifida Hemsley (S. Wats.) Mathias & Constance (Umbelliferae) is 
one of 38 species of the genus Arracacia found in the Sierra Madre mountains of Mexico down 
through the Andes in South America. The plant is a tall perennial herb that grows commonly in 
the dry grasslands and oak-juniper woodlands of Mexico ranging in altitude from 2250 to 
2950 m over the sea level, from the States of Durango to Hidalgo south through Oaxaca. Local 
population refer to this species by its Nahuatl name, “acocotli”, or the common Spanish names of 
“comino rústico”, “hierba del oso” and “neldo”. The fruits and aerial parts of Arracacia 
tolucensis var. multifida have been used as carminative and digestive stimulant agent along 
with Arracacia atropurpurea (Lehm.) Benth. & Hook (Martínez, 1989). It has also been 
employed for treating gonorrhea, fevers and anger (Argueta, 1994). The fruits have been 
employed in the past as a condiment and the plant eaten as food (Bois, 1904). Although 
Arracacia tolucensis var. multifida has not been previously investigated from the chemical point 
of view, studies on the related species Arracacia vaginata and Arracacia nelsonii led to isolation 
of several pyranocoumarins, phenylpropanoids and monoterpenoids (Calderon and Ríos, 
1975, Delgado and Garduño, 1987). Recently we demonstrated that the crude extract of this 
species was not toxic for mice or mutagenic when tested by the Lorke and Ames procedures, 
respectively (Déciga et al., 2007). 
 
Despite the continued use of Arracacia tolucensis var. multifida its composition and 
pharmacological properties as well as the quality control procedures for the crude drug have not 
been established yet. Therefore, the present study was undertaken (i) to determine the potential 
antispasmodic action, chemical composition and active principles of the extract and essential oil 
of Arracacia tolucensis var. multifida and (ii) to develop an analytical method using HPLC to 
quantify the most important active principles of the plant. Altogether, the results of these studies 
will be useful for establishing quality control and preclinical pharmacological parameters for the 
elaboration of scientific and pharmacopoeic monographs of this Mexican medicinal plant. 
 
2. Materials and methods 
 
2.1. General experimental procedures 
 
IR spectra were obtained on a Perkin-Elmer 599-B spectrophotometer. 1H NMR (300 and 
400 MHz) and 13C NMR (75 and 100 MHz) spectra were recorded in a Varian VXR-300S or 
Varian Unit Inova spectrometer in CDCl3 using tetramethylsilane (TMS) as an standard internal. 
EI mass spectra (ionization energy of 70 eV) were obtained on a HP 5890 spectrometer. HPLC 
was carried out with a Waters HPLC instrument equipped with Waters Dual 2487 detector. 
Control of equipment, data acquisition, processing and management of chromatographic 
information were performed by the Millenium 2000 software program (Waters). The analyses 
were carried out on a Nova-Pak® column (300 mm × 3.9 mm, 6 μm particle size, Waters). The 
mobile phase was an isocratic Hex–CH2Cl2–MeOH (80:7:13) system. The flow rate was kept 
constant at 0.6 mL/min for 30 min. All solvents and reagents were analytical grade n-hexane, 
CH2Cl2, MeOH and EtOAc were obtained from Merck (Darmstadt, Germany) and Burdick & 
Jackson (Muskegon, USA). GHP® membrane filters (0.45 μm) for the mobile phase were 
supplied by Pall Corporation (New York, USA) and PVDF® membranes (0.45 μm) for the 
preparation of samples before HPLC injection were from Whatman (Germany). GC–MS analysis 
was carried out in a JEOL JMS-AXOCCHA gas chromatograph interfaced to a Hewlett Packard 
5890 mass spectrometer equipped with a 30 m long × 0.32 mm i.d. × 0.30 μm film thickness 
composed of 5% phenylmethylsilicon HP column, connected to an ion trap detector operating in 
the electron impact mode at 70 eV; carrier gas was He, flow rate 1 mL/min and injection volume 
of 20 μL (in CH2Cl2). The oven temperature was programmed from 150 to 300 °C with increase 
of 10 °C/min. Column chromatography (CC) was carried out using silica gel 60 (Merck, 70–
230 μm; ASTM, 0.063–0.200 nm). Thin layer chromatography (TLC) was performed on plates 
with silica gel 60 F254 (Merck, 0.25 mm); visualization of plates was carried out using a ceric 
sulphate (10%) solution in H2SO4. 
 
2.2. Plant material 
 
The aerial parts of Arracacia tolucensis var. multifida were collected southern Mexico City, 
Mexico on September 1999 (batch 1) and January 2004 (batches 2 and 3). The species was 
identified by Dr. Robert Bye from the Biology Institute of UNAM. Voucher specimens (Bye & 
Morales 27040 and Bye 33821, respectively) have been deposited at the National Herbarium of 
Mexico (MEXU), UNAM, Mexico City. 
 
2.3. Extraction and Isolation 
 
2.3.1. Essential oil 
 
The essential oil (4 g) was obtained by hydrodistillation from the aerial parts (batch 1, 1.0 kg). 
Major constituents of the essential oil were identified by matching their 70 eV mass spectra with 
those of the reference library. In the case of 1, 2, 4 and 9 the identities were established by 
comparison with authentic samples. 
 
2.3.2. Extraction and isolation 
 
The air-dried aerial parts (batch 1, 2.0 kg) was ground into powder and extracted by maceration 
with CH2Cl2–MeOH (1:1, 10 L) at room temperature. After filtration, the extract was evaporated 
under reduced pressure to yield 160 g of residue. 
 
The organic extract was subjected to open column chromatography on silica gel (1.0 kg) and 
eluted with a gradient of Hex–EtOAc (1:0 → 0:1) and EtOAc–MeOH (1:0 → 0:1). Fractions of 
200 mL each were collected and then combined according their TLC patterns to yield seven 
primary fractions (F1–F7). Each primary fraction was tested for its antimycobacterial activity. 
From fraction F1 (GI of Mycobacterium tuberculosis = 99%) eluted with Hex–EtOAc (9:1) 
crystallized 500 mg (0.025%) of compound 1. HPLC purification of the mother liquors from 
fraction F1 [0.5 mL/min, Hex–CH2Cl2–EtOAc (70:25:5)] yielded 2 (100 mg, 0.005%) 
and 3 (30 mg, 0.0015%). The retention times were 12.61 and 19.50 min, respectively. 
 
Fraction F2 (GI of Mycobacterium tuberculosis = 100%), eluted with Hex–EtOAc (8:2), was 
subjected to open column chromatography on silica gel (170 g) and eluted with a gradient of 
increasing polarity of CH2Cl2–MeOH (1:0 → 0:1), afforded five secondary fractions (F2-I–F2-V). 
Preparative TLC of F2-II using CH2Cl2–MeOH (9:1) yielded 6 (17 mg, 0.00085%, pf 143–
145 °C). HPLC purification of F2-III [0.35 mL/min, CH2Cl2–MeOH (99:1)] afforded the known 
coumarins 1 (50 mg, 0.0025%), 4 (70 mg, 0.0035%) and 5 (10 mg, 0.0005%); retention times: 
18.76, 20.48 and 21.94 min, respectively. 
 
Fraction F4 (GI of Mycobacterium tuberculosis = 96%) eluted with Hex–EtOAc (1:1) was 
rechromatographed on a Si gel (300 g) open column eluting with a gradient CH2Cl2–MeOH 
(1:0 → 0:1). Eight secondary fractions were obtained (F4-I–F4-VIII). Extensive TLC [CH2Cl2–
MeOH (9:1)] of F4-IV yielded 7 (35 mg, 0.00175%, pf 230–232 °C). Further purification of 
secondary fraction F4-V by preparative TLC [CH2Cl2–MeOH (95:5)] led to isolation of 8 (25 mg, 
0.00125%, pf 134–135 °C). 
 
Primary fraction F5 (GI of Mycobacterium tuberculosis = 99%) eluted with Hex–EtOAc (3:7) 
was rechromatographed on a Si gel column using a gradient system of CH2Cl2–MeOH 
(1:0 → 0:1). Seven secondary fractions were obtained (F5-I–F5-VII). HPLC purification [Hex–
CH2Cl2–EtOAc (40:30:30)] of F5-II afforded 11 (12 mg, 0.0006%, Rt 9.49, pf 230–232 °C). 
Finally, preparative TLC of F5-VII using CH2Cl2–MeOH (95:5) yielded 9 (20 mg, 0.001%, pf 
187–188 °C) and 10 (25 mg, 0.00125%, pf 178–180 °C). 
 
2.4. Quantitative analyses of the crude extract (batches 1–3) 
 
Calibration curves were prepared independently by dissolving the appropriate amount of each 
compound in CH2Cl2 to obtain final concentrations ranging from 0.75 to 25.0 μg/mL. All 
compounds were detected at 285 nm. A volume of 20 μL was injected. The calibration curves 
were based on the peak areas of the HPLC chromatograms. The experiments were performed by 
sextuplicate. The values were expressed in terms of percentage on the basis of the concentration 
injected. Furthermore, three different concentrations of coumarins 1, 2, 4 and 9 were added to a 
sample of the crude extract. The added concentrations were used to confirm the amount of 
compounds 1, 2, 4 and 9 in the crude extract by means of the standard addition method (ICH 
Q2(R1), 2005). Validation test materials (coumarins 4 and 9) were purchased from Sigma (St. 
Louis, MO, USA) or isolated (1 and 2) as described above. 
 
2.5. Antimicrobial disk assay 
 
Gram-positive bacteria [Bacillus subtilis (ATCC 6633) and Staphylococcus aureus (ATCC 
25932)] and Gram-negative bacteria [Escherichia coli (ATCC 10536), Salmonella typhi (ATCC 
9992) and Pseudomonas aeruginosa (ATCC 27853)] were used for antimicrobial tests. All 
microorganisms were provided by Culture Collection at School of Chemistry, UNAM. The 
bacterial strains were grown in Müeller-Hinton agar (MHA) plates at 37 °C (Mitscher et al., 
1987, NCCLS, 1997, NCCLS, 2003, Ojala et al., 2000, Alderman and Smith, 2001). Agar plates 
containing 1 mL (106 bacteria/mL) of an overnight broth culture were prepared. Disks having a 
diameter of 6.0 mm were impregnated with 5 μL of each sample at a final concentration of 100, 
250, 500, 750 or 1000 μg were placed on the inoculated plates. Similarly, each plate carried a 
blank disk, with solvent only (DMSO) and antibiotic disk of amikacin (CIC = 0.15 μg/μL; 
Staphylococcus aureus), vancomicin (CIC = 0.10 μg/μL; Bacillus subtilis), gentamicin 
(CIC = 0.20 and 0.05 μg/μL; Pseudomonas aeruginosa and Escherichia coli, respectively) and 
ciprofloxacin (CIC = 0.015 μg/μL; Salmonella typhi). All the plates were incubated at 37 °C for 
24 h. The susceptibility of each microorganism to the samples (crude extract and essential oil) 
was determined by measuring the sizes of the inhibitory zones on the agar surface around the 
disks, and values <8 mm were considered as non-active against bacteria. All of the experiments 
were performed by cuadruplicate. The results are reported as critical inhibitory concentration 
(CIC) defined as the lowest concentration at which no bacteria growth inhibition was observed 
after incubation at 37 °C for 24 h. 
 
2.6. Antimycobacterial activity 
 
Activity of the crude extract, fractions and isolated compounds was determined against 
Mycobacterium tuberculosis H37Rv (ATCC 27294) in the Microplate Alamar Blue Assay 
(MABA) as previously described. The growth of the bacteria is represented as a numerical value 
called the growth index (GI). The percentage inhibition was defined as (1 − (GI of test sample/GI 
of control) × 100). The activity of pure compounds was expressed as the lowest drug 
concentration that affected an inhibition of ≥90% relative to untreated cultures (MIC). Rifampin 
was used as a positive control (MIC = 0.1 μg/mL). 
 
2.7. Spasmolytic activity 
 
2.7.1. Isolated guinea-pig ileum test 
 
All experiments were performed following the Mexican Official Norm for Animal Care and 
Handing (NOM-062-ZOO-1999). Each piece of ileum (1–1.5 cm long) from a freshly killed 
male guinea pig was suspended in a tissue chamber containing 10 mL of Tyrode solution with 
composition (mM): NaCl 149.2; KCl 2.7; MgCl2·6H2O 2.1; CaCl2 3.6; NaH2PO4 0.4; 
NaHCO3 11.9; glucose 5.0; pH 7.4, at 37 °C, continuously gassed with carbogen (95% O2 + 5% 
CO2). The contractions were recorded with an isometrical force transducer (Grass FT 03) 
connected to a MP100 Manager Biopac System polygraph. The data were digitalized and 
analyzed by mean of software for data acquisition (Acknowledge 3.7.3). Tissues were placed 
under a resting tension of 1.0 g and allowed to stabilize for 45 min and they were washed with 
fresh Tyrode solution at 15 min intervals before starting the experiments. After the stabilization 
period the tissues were contracted with carbachol (1 × 10−6 M) to assess its viability. The extract 
and essential oil suspended in 0.5% Tween 80 in water were added to the bath in a volume of 
100 μL at final concentrations of 3, 10, 30, 100, 300 and 1000 μg/mL. All responses were 
recorded during 10 min. The antispasmodic activity of the extract was assessed by its ability to 
prevent the contractions induced by a submaximal concentration experimentally determined of 
acetylcholine (1 × 10−4 M), histamine (1 × 10−3 M), serotonine (1 × 10−4 M) and 
BaCl2 (1 × 10−2 M). Papaverine was used as positive control. All the results are expressed as the 
mean of six experiments ± S.E.M. Concentration–response curves (CRC's) for the extract and oil 
were plotted and the experimental data were adjusted by nonlinear least squares, curve fitting 
program (SigmaStat). The statistical significance (p < 0.05) of differences between means was 
assessed by an analysis of variance (ANOVA) followed by a Turkey's test. 
 
3. Results and discussion 
 
3.1. Antibacterial activity 
 
Since Arracacia tolucensis var. multifida is used as an antiinfective agent, a CH2Cl2–MeOH 
(1:1) extract was tested against Mycobacterium tuberculosis using the Alamar Blue procedure 
(Collins and Franzblau, 1997). The results revealed that the extract significantly inhibited 
Mycobacterium tuberculosis growth (GI = 99%). Bioassay guided fractionation of the active 
extract using silica gel column chromatographic revealed that primary chromatographic fractions 
F1–F5 concentrated the activity (see Section 2.1). Extensive chromatographic separation of the 
active fractions led of the isolation of 11 coumarins (Fig. 1) which were identified by IR, NMR 
and MS methods as isoimperatorin (1), osthol (2), suberosin (3), 8-methoxypsoralen (8-MOP) 
(4), herniarin (5), scoparone (6), umbelliferone (7), dihydroxypeucedanin (8), 5-methoxypsoralen 
(5-MOP) (9), isoscopoletin (10) and scopoletin (11) (Ivie, 1978, Harkar et al., 1984, Estevez-
Braun and González, 2002). 
 
 
Fig. 1. Structures of coumarins 1–11. 
 
In general the spectroscopic data were in agreement with those previously described for 
compounds 1–11 (Ivie, 1978, Harkar et al., 1984, Estevez-Braun and González, 2002). Briefly, 
the common feature of all structures is the benzo-α-pyrone unit differing only in the nature of the 
substituents (i.e. hydroxy, methoxy, isoprenyloxy, isoprenyl or furan) along the benzene core. 
The NMR data of compounds 1–11 showed strong similarities albeit partial. The 13C NMR and 
IR spectra confirmed the α-pyrone unit since the characteristic carbonyl absorption was observed 
at ∼160 ppm and ∼1720 cm−1, respectively. In all cases, the 1H NMR spectra in the region 
between 6 and 8.2 ppm showed the typical AB system for H-3 and H-4 and signals for the 
aromatic. The nature of the substituents was determined by means of the analysis of the NMR 
spectra which revealed resonances for methoxyl, hydroxyl, furan or different isoprenyl moieties. 
The position of the substituents in the aromatic ring was established on the basis of the splitting 
pattern of the aromatic hydrogens (Ivie, 1978, Harkar et al., 1984, Estevez-Braun and González, 
2002). 
 
The isolates were tested against Mycobacterium tuberculosis and only compounds 1–4 showed 
significant anti-TBC activity with MIC values of 64, 32, 16 and 128 μg/mL, respectively. 
Compounds 5–11 displayed MIC values higher than 128 μg/mL. The better activity of 1–3 over 
the remaining compounds are in agreement with the observations of Schinkovitz et al. (2003) 
who found that the presence of an isoprenyl unit attached to the carbocyclic ring of some 
coumarins provoked an increment of their antimycobacterial properties. Also these authors 
demonstrated that umbelliferone (7) was weakly active against Mycobacterium fortuitum. 
 
The extract and essential oil of Arracacia tolucensis var. multifida was also tested against an 
appropriated battery of Gram-positive and Gram-negative bacteria using the disk diffusion 
method. The crude extract was active against Staphylococcus aureus and Bacillus subtilis; the 
CIC values were 9.92 and 27.7 μg/μL, respectively. On the other hand, the essential oil showed 
moderate in vitro antibacterial activity against both Gram-positive (Staphylococcus aureus and 
Bacillus subtilis) and Gram-negative bacteria (Salmonella typhi, Escherichia coli and 
Pseudomonas aeruginosa) with CIC values of 50.4, 99.8, 150.2, 150.1 and 147.9 μg/μL, 
respectively. The susceptibility of common Gram-negative and Gram-positive to the tested 
material was poorer in comparison with that of standard antibiotics. 
 
3.2. Essential oil composition 
 
The volatile oil of Arracacia tolucensis var. multifida was analyzed by GC–MS and found to be 
composed mainly by osthol (2), suberosin (3), 8-MOP (4), 5-MOP (9), benzyl alcohol, terpinen-
4-ol and α-cadinene. Near a 50% of the constituents were identified, being compounds 2 and 3 
the major active principles. In the case of compounds 2–4 and 9 the identities were established 
by comparison with authentic samples. The Rt's (retention times) for compounds benzyl alcohol, 
terpinen-4-ol, α-cadinene, 9, 4, 2 and 3, were 9.13, 11.66, 16.24, 23.27, 23.46, 24.18 and 
24.84 min, respectively. 
 
3.3. Spasmolytic activity 
 
The use of Arracacia tolucensis var. multifida as carminative and digestive stimulant agent 
suggested that this species could have spasmolytic properties. In order to corroborate this 
hypothesis, the effect of both a CH2Cl2–MeOH (1:1) extract and the essential oil prepared from 
the aerial parts of the plant on the spontaneous contraction of the guinea-pig ileum was assessed. 
The results of the pharmacological testing revealed that both preparations provoked a 
concentration dependent inhibition of the tone and amplitude of the guinea-pig ileum 
spontaneous contractions (Fig. 2a). The essential oil (IC50 = 116.4 ± 23.2 μg/mL) was more 
active than the crude extract (IC50 = 1153.1 ± 53.2 μg/mL), although three times less active than 
papaverine (IC50 = 35.0 ± 1.4 μg/mL) used as positive control (Fig. 3). The influence of the 
extract and essential oil on histamine-, acetylcholine-, serotonine- and BaCl2-induced smooth 
muscle contractions was also investigated (Fig. 2b and c). The crude extract as well as the 
essential oil antagonized the contractions exerted by acetylcholine (1 × 10−4 M), histamine 
(1 × 10−3 M), serotonine (1 × 10−4 M) and BaCl2 (1 × 10−2 M) as is showed resumed in Table 1. 
Altogether this information revealed that the smooth muscle relaxant activity displayed by the 
extract and essential oil of Arracacia tolucensis var. multifida involved an unspecific inhibition 
of the calcium influx into the smooth muscle cells (Rojas et al., 1995, Rojas et al., 1996). 
 
 
Fig. 2. Tracing of guinea-pig ileum muscle showing the response contractile by (a) essential oil 
(1000 μg/mL), (b) spasmogen (BaCl2 1 × 10−2 M) and (c) spasmogen after treatment with 
essential oil (1000 μg/mL) during 10 min. The arrows indicate the treatment added to the bathing 
fluid. 
 
 
Fig. 3. Concentration–response curves showing the relaxatory effect of the extract and essential 
oil from Arracacia tolucensis var. multifida on the spontaneous contractions of isolated guinea-
pig ileum. Values are expressed as the percentages of inhibition of contractile responses 
calculated as the mean from six different animals ± S.E.M., p < 0.05. 
 
Table 1. Effect of extract and essential oil from Arracacia tolucensis var. multifida on the 
contractions induced by acetylcholine, histamine, serotonine and BaCl2 on isolated guinea-pig 
ileum 
Sample Acetylcholine (1 × 10−4 M) 
Histamine 
(1 × 10−3 M) 
Serotonine 
(1 × 10−4 M) BaCl2 (1 × 10
−2 M) 
IC50 (μg/mL) ± S.E.M. 
 Extract 38.7 ± 12.3 53.4 ± 32.5 15.2 ± 5.1 27.8 ± 5.0 
 Essential 
oil 30.0 ± 2.8 23.7 ± 5.0 11.1 ± 1.5 15.4 ± 4.9 
 Papaverinea 12.7 ± 4.1 12.8 ± 4.3 9.0 ± 1.8 11.3 ± 3.2 
 
Emax (10−3 μg/mL) ± S.E.M. 
 Extract 97.2* ± 1.1 98.2* ± 0.7 99.7* ± 0.1 99.3* ± 0.5 
 Essential 
oil 98.8
* ± 0.6 98.4* ± 0.4 98.8* ± 0.1 98.9* ± 0.5 
 Papaverinea 100.0* ± 0.0 100.0* ± 0.0 100.0* ± 0.0 100.0* ± 0.0 
Values are expressed as the percentages of inhibition of contractile responses calculated as the mean from six 
different animals ± S.E.M., *p < 0.05 (ANOVA). 
a Positive control. 
 
The presence of compounds 2 (Li et al., 1994, Chen et al., 2000, Che-Ming et al., 
2004), 4, 9 (Call and Green, 1956, Novak et al., 1967), 6 (Liu et al., 2002) and 10 (Reisch et al., 
1966) with known spasmolytic properties could account for the antispasmodic activity of the 
extract and oil of Arracacia tolucensis var. multifida. Osthol (2) and 5-MOP (9) antagonized the 
contractions evoked by acetylcholine, histamine, BaCl2 and KCl on isolated rat ileum 
preparations. In addition, Teng et al. (1994) reported that osthol (2) inhibited calmodulin 
sensitive phosphodiesterase (PDE1) on trachea smooth muscle. 
 
3.4. Quantitative HPLC analysis 
 
To develop a suitable HPLC fingerprint and a method to quantify the major coumarins of the 
extract of Arracacia tolucensis var. multifida, three different samples were collected in two 
different seasons (Fig. 4). The calibration curves (Table 2) indicated the linearity of the detector 
response for the four standard analytes from 0.75 to 25.0 μg/mL. The limit of detection (LOD) 
ranged from 0.15 to 0.47 μg/mL for the standard analytes. The reproducibility and repeatability 
of the analytical method were evaluated in terms of the intermediate precision by analyzing three 
replicates of six samples of stock solution (12.5 μg/μL) on 3 different days. The relative standard 
deviation (R.S.D.) [n = 6] and coefficient of variation (CV) were calculated for each batch. The 
results indicated that their chromatographic pattern were similar showing in each case the 
presence of four peaks assigned as 1, 2, 9 and 4. The CV values (≤3.0) and the precision of 
retention times and peak areas of compounds 1, 2, 4 and 9 for replicated injections. In order to 
determine the accuracy of the method, one sample was spiked with a known amount of the 
standard analytes 1, 2, 4 and 9. Recovery ranges were found to be between 97.5 and 102.5%. 
Finally, this HPLC method was used to quantify the coumarins 1, 2, 4 and 9 in the crude extract 
of Arracacia tolucensis var. multifida (Table 3). 
 
 
Fig. 4. HPLC chromatrogam of crude extract from Arracacia tolucensis var. multifida of three 
different batches (b1–b3). 
 
Table 2. Calibration data [regression equation and correlation coefficient (r2)] and LOD for 
coumarins 1, 2, 4 and 9 
Analyte Regression equation r2 LOD (μg/mL) 
1 y = 1.34 × 108x + 4.14 × 104 0.9999 0.47 
2 y = 1.10 × 108x + 1.26 × 105 0.9999 0.19 
4 y = 1.65 × 108x + 6.58 × 105 0.9989 0.15 
9 y = 1.53 × 108x − 2.45 × 105 0.9999 0.22 
 
Table 3. Quantification of the coumarins 1, 2, 4 and 9 (mg/g of extract) by HPLC analysis 
Compound Batch 1 Batch 2 Batch 3 
1 9.8 ± 1.0 16.6 ± 0.8 15.8 ± 1.2 
2 25.8 ± 4.0 60.2 ± 5.8 57.0 ± 6.4 
4 67.4 ± 1.8 61.8 ± 3.8 58.8 ± 3.0 
9 46.0 ± 5.8 42.0 ± 1.0 39.4 ± 1.4 
 
4. Conclusions 
 
The organic extract and the essential oil from the aerial parts of Arracacia 
tolucensis var. multifida showed significant spasmolytic activity; this action could be useful to 
regulate gastrointestinal disorders associated with indigestion or anomalous gastrointestinal 
motility. The crude extract also showed noted antimycobacterial action against Mycobacterium 
tuberculosis; the latter effect could be related with the use of the plant as an antiinfective agent. 
The biological properties for Arracacia tolucensis found in this study were related with its high 
coumarin content. Four of the coumarins isolated and characterized were active either as 
spasmolytic or antimycobacterial agents, therefore, it is highly probably that these compounds 
contributed synergistically to the pharmacological actions exhibited by the crude extract or 
essential oil of Arracacia tolucensis var. multifida. The antimycobacterial activity of 
isoimperatorin (1), osthol (2), suberosin (3) and 8-methoxypsoralen (8-MOP) (4) is newly 
described. 
 
The coumarins isolated from Arracacia tolucensis var. multifida has not been isolated from the 
related species so far investigated which contain pyranocoumarins, phenylpropanoids and 
monoterpenoids. 
 
A suitable (novel and rapid) HPLC method to quantify the major active coumarins of the plant 
was developed. The method provides also a reproducible fingerprint useful for identity tests of 
this plant. 
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